High Tide Inc. (HITI) is a Medical - Pharmaceuticals company in the Healthcare sector, currently trading at $2.34. It has a SharesGrow Score of 37/100, indicating a weak investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of HITI = $254.95 (+10795.3% from the current price, the stock appears undervalued). Analyst consensus target is HITI = $3 (+15.4% upside).
Valuation: HITI trades at a trailing Price-to-Earnings (P/E) of -5.9 (S&P 500 average ~25).
Financials: revenue is $594M, +19.2%/yr average growth. Net income is $51M (loss), growing at -312.2%/yr. Net profit margin is -8.5% (negative). Gross margin is 25.8% (-2.5 pp trend).
Balance sheet: total debt is $150M against $88M equity (Debt-to-Equity (D/E) ratio 1.71, leveraged). Current ratio is 1.37 (adequate). Debt-to-assets is 42.9%. Total assets: $349M.
Analyst outlook: 3 / 4 analysts rate HITI as buy (75%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 75/100 (Pass), Growth 48/100 (Partial), Past 0/100 (Fail), Health 17/100 (Fail), Moat 28/100 (Fail), Future 79/100 (Pass), Income 10/100 (Fail).
